Announcements

Removal of Component(s) - AVXS

May 9, 2018

LifeSci Biotechnology Clinical Trials Index

Removal of Component(s) – AVXS

5/9/2018

Effective at the market close on Monday, May 14, 2018, AVXS will be removed from the LifeSci Biotechnology Clinical Trials Index and its value will be redistributed to the remaining index components based on their weights.

On 4/9/2018, AveXis (AVXS) announced that it will be acquired by Novartis AG for $218 per share in cash.